This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Embryology

Authoring team

The left atrium of the heart forms from two sources:

  • the initial auricle:
    • forms after division of the common atrium by septum formation during the fourth week of fetal life
    • eventually forms the minority of the left atrium - represented mainly by the left auricle - in the mature heart due to relative growth of the pulmonary veins
  • the pulmonary veins:
    • forms the majority of the mature heart and is smooth-walled
    • after the formation of the initial auricle:
      • an embryonic pulmonary vein develops as a projection from the posterior wall passing posteriorly
      • the vein joins those of the developing lung buds
      • all the veins enlarge
      • the main embryonic vein becomes incorporated into the posterior wall of the left atrium
      • due to relative growth, one superior and one inferior pulmonary vein enter the left atrium directly on each side

The fusion of the primitive pulmonary vein with the pulmonary veins derived from the lung buds may stop prematurely or progress excessively. This may lead to, respectively, only one main pulmonary vein or five to six entering the left atrium. Three veins instead of four is the most common deviation from the normal pattern. Usually, two or fewer veins entering the left atrium is associated with gross cardiac abnormalities and fetal abortion.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.